Sign in

NCT03297775Recruiting

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Source: ClinicalTrials.gov · Last updated 1 May 2026

Brief summary (registry, in English)

The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g. clinical features, genetic variants, and/or biologic markers) between other forms of ILD (e.g. idiopathic pulmonary fibrosis, IPF) and subclinical RA-ILD that places individuals at risk for the development of lung disease.

Status (registry)
Recruiting
Study type
Observational
Enrollment
750 (estimated)
First submitted
19 Sept 2017
Start date
22 Jun 2017
Primary completion date
30 Jun 2027
Lead sponsor
University of Colorado, Denver
NCT number
NCT03297775

What you commit to

  • Study type: Observational
  • Planned participants: 750
  • From 22 Jun 2017 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of interstitial lung disease
  • Evidence of other causes of diffuse parenchymal lung disease such as infection, drug toxicity, other autoimmune processes, etc.

Age

  • Subjects over the age of 90 years old or less than 45 years old

Other

  • Inability to give informed consent
  • Pregnant women

Who the study is looking for

  • ≥ 45years old
  • Diagnosis of RA using the 2010 American College of Rheumatology (ACR) criteria

Age in the registry: 45 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Colorado Anschutz Medical Campus
Coordinator of this site? Confirm its status		AuroraUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.